Azbil BioVigilant, Inc., inventors of Instantaneous Microbial Detection™, recently announced that the Company has successfully resolved its dispute with TSI concerning TSI’s U.S. patent number 6,831,279.
Last week, TSI filed a notice with the U.S. Patent and Trademark Office, which in effect, will result in the termination of the patent. In addition, TSI and Azbil BioVigilant jointly filed a request to dismiss TSI’s appeal of the U.S. District Court’s ruling where the underlying claims of TSI’s patent were found to be invalid.
“We are pleased to bring this patent litigation to a conclusion. This ends, once and for all, the threat the suit presented to our customers,” said Aric Meares president and CEO of Azbil BioVigilant.
Representing Azbil BioVigilant in its patent litigation was Amster, Rothstein & Ebenstein LLP.
Last week, TSI filed a notice with the U.S. Patent and Trademark Office, which in effect, will result in the termination of the patent. In addition, TSI and Azbil BioVigilant jointly filed a request to dismiss TSI’s appeal of the U.S. District Court’s ruling where the underlying claims of TSI’s patent were found to be invalid.
“We are pleased to bring this patent litigation to a conclusion. This ends, once and for all, the threat the suit presented to our customers,” said Aric Meares president and CEO of Azbil BioVigilant.
Representing Azbil BioVigilant in its patent litigation was Amster, Rothstein & Ebenstein LLP.